Frequently asked questions Is migraine a disability? What rights do I have at work? It may be – the answer depends upon your own individual circumstances. As a migraine sufferer, you are likely to be classified as disabled if your migraine headaches have a long term and substantial effect on your ability to carry out […]
Migraine at work -Questions Read More »
Positive results from a Phase III HALO study of fremanezumab, an anti-calcitonin gene-related peptide (CGRP) monoclonal antibody investigational treatment for the prevention of migraine, have been announced by Israel-based Teva Pharmaceutical Industries (NYSE: TEVA). In the chronic migraine (CM) study, patients treated with fremanezumab experienced statistically-significant reduction in the number of monthly headache days of
Positive Phase III data for migraine drug Fremanezumab Read More »
At this meeting Elena Ruiz de la Torre will spend Apr. 45 minutes talking about EMHA as an organisation, and how she sees they can work together with the Nordic countries.
Meeting with Novartis in Tallin Read More »
The European Headache Federation (EHF) and the European Migraine Headache Alliance (EMHA) are pleased to announce the 21st March as the first Cluster Headache Day as part of the ‘What’s the Under the Hat?’ public awareness campaign. Cluster headache is one of the worst pains known to man and affects up to 4 in 1,000
Let me set the scene of motherhood with migraines : a Monday evening in late January. My husband had been working like a dog for over a week and I had barely seen him in days. The kids were just getting over their latest in a series of winter illnesses and they were post-sick exhausted
One Tough Challenge: Motherhood with Migraines Read More »
OBJECTIVES: The aim of this study was to evaluate the efficacy of greater occipital nerve (GON) block in the treatment of migraine patients. METHODS: This study included 28 patients diagnosed with migraine between 2014 and 2015. The GON block procedure was applied by administering 1.5 ml of 2% lidocaine 2 cm lateral and 2 cm
The results of greater occipital nerve block applied for migraine headache Read More »
Patients with chronic migraine share features with individuals with temporomandibular disorders that include kinesiophobia and neck disability, according to a cross-sectional study recently published in Pain Medicine.1 A growing body of research indicates a number of shared features between chronic migraine and TMD. For example, patients with chronic migraine, but not headache-free individuals, commonly experience
Disability & Catastrophizing In Chronic Migraine vs Temporomandibular Disorder Read More »
The year 2017 marks the 50th anniversary for spinal cord stimulation therapy which was first used to treat pain in 1967. To celebrate the occasion, NeuroNews spoke to a number of pioneers in the field about how they have seen spinal cord stimulation therapy change and develop over the years and where they hope to see it
Marking 50 years of spinal cord stimulation Read More »
The Migraine Association of Ireland is going on a ‘road-trip’! In October of 2017 they will be traveling the country to locations they seldom get the chance to visit and holding information stands in various places. So keep an eye out for them if you live in the following counties; Galway, Mayo, Sligo, Waterford, Wexford, Carlow, Kilkenny, They will be
Road trip 2017- Migraine Association of Ireland Read More »
